advertisement

---

Sawhney G 8

Showing records 1 to 8 | Display all abstracts from Sawhney G

125399 Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE Study
Bacharach J
Clinical Ophthalmology 2025; 19: 175-186

---

126957 Prospective 18-Month Study of Bimatoprost Intracameral Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension in US Clinical Practice
Mann E; Kammer JA
Drugs 2025; 85: 397-414

---

125399 Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE Study
Sadri E
Clinical Ophthalmology 2025; 19: 175-186

---

126957 Prospective 18-Month Study of Bimatoprost Intracameral Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension in US Clinical Practice
Sawhney G
Drugs 2025; 85: 397-414

---

125399 Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE Study
Sawhney G; Kopczynski C
Clinical Ophthalmology 2025; 19: 175-186

---

126957 Prospective 18-Month Study of Bimatoprost Intracameral Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension in US Clinical Practice
An J
Drugs 2025; 85: 397-414

---

125399 Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE Study
Merchea MM
Clinical Ophthalmology 2025; 19: 175-186

---

126957 Prospective 18-Month Study of Bimatoprost Intracameral Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension in US Clinical Practice
Werts EC; Vera V; Rivas M; Lai H; Sonparote S; Craven ER
Drugs 2025; 85: 397-414

---